Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer. (Q53286511)

13 May 2018

title

Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer. (English)

1 reference

13 May 2018

author name string

Juan Zhang

1

1 reference

13 May 2018

Renguang Pei

2

1 reference

13 May 2018

Zhiyuan Pang

3

1 reference

13 May 2018

Tao Ouyang

4

1 reference

13 May 2018

Jinfeng Li

5

1 reference

13 May 2018

Tianfeng Wang

6

1 reference

13 May 2018

Zhaoqing Fan

7

1 reference

13 May 2018

Tie Fan

8

1 reference

13 May 2018

Benyao Lin

9

1 reference

13 May 2018

Yuntao Xie

10

1 reference

13 May 2018

language of work or name

English

0 references

publication date

26 May 2011

1 reference

13 May 2018

Breast Cancer Research and Treatment

published in

1 reference

13 May 2018

volume

132

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

page(s)

421-428

1 reference

13 May 2018

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

Identification of the breast cancer susceptibility gene BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

Breast cancer genetics: what we know and what we need

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

Variation of breast cancer risk among BRCA1/2 carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

Meta-analysis of BRCA1 and BRCA2 penetrance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

Personalized Medicine: A Personal View

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

Mutational screening of breast cancer susceptibility gene 1 from early onset, bi-lateral, and familial breast cancer patients in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

Performance of BRCA1/2 mutation prediction models in Asian Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

Familial risks of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

Clinical and pathologic differences between BRCA1-, BRCA2-, and non-BRCA-associated breast cancers in a multiracial developing country

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

The pathology of hereditary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

The pathology of inherited breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1596-X

10.1007/S10549-011-1596-X

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018